Falkman L.; Sundin A.; Skogseid B.; Botling J.; Bernardo Y.; Wallin G.; Zhang L.; Welin S.; Lase I.; Mollazadegan K.; Crona J. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Upsala Journal of Medical Sciences, v. 129, n. S1, p. e10660, 9 Apr. 2024.